Yepeng Luan

1.2k total citations
43 papers, 989 citations indexed

About

Yepeng Luan is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yepeng Luan has authored 43 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Yepeng Luan's work include Histone Deacetylase Inhibitors Research (16 papers), Peptidase Inhibition and Analysis (14 papers) and Protein Degradation and Inhibitors (12 papers). Yepeng Luan is often cited by papers focused on Histone Deacetylase Inhibitors Research (16 papers), Peptidase Inhibition and Analysis (14 papers) and Protein Degradation and Inhibitors (12 papers). Yepeng Luan collaborates with scholars based in China, United States and France. Yepeng Luan's co-authors include Wenfang Xu, Jean Bernatchez, Jerry Li, Rongshi Li, Dehai Li, Qianqun Gu, Tianjiao Zhu, Xuehong Chen, Wenjun Li and Liyuan Li and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Yepeng Luan

43 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yepeng Luan China 15 464 284 248 151 84 43 989
S.M. Soisson United States 19 1.1k 2.4× 277 1.0× 192 0.8× 167 1.1× 45 0.5× 32 1.6k
Kouhei Matsui Japan 18 632 1.4× 265 0.9× 190 0.8× 170 1.1× 225 2.7× 26 1.5k
Paola Lo Surdo Italy 19 1.2k 2.7× 141 0.5× 308 1.2× 61 0.4× 54 0.6× 38 1.9k
Patrick Vlieghe France 9 1.1k 2.3× 296 1.0× 184 0.7× 53 0.4× 38 0.5× 13 1.5k
Pengfei Fang China 19 821 1.8× 179 0.6× 103 0.4× 51 0.3× 25 0.3× 59 1.1k
Yaxue Zhao China 17 782 1.7× 161 0.6× 121 0.5× 47 0.3× 21 0.3× 44 1.2k
Salvatore Di Maro Italy 25 755 1.6× 227 0.8× 260 1.0× 57 0.4× 17 0.2× 63 1.3k
Charles A. Omer United States 29 1.5k 3.2× 295 1.0× 499 2.0× 191 1.3× 78 0.9× 52 2.1k
Tomowo Kobayashi Japan 19 487 1.0× 186 0.7× 234 0.9× 121 0.8× 86 1.0× 27 1.0k
Juan Manuel Domı́nguez Spain 16 556 1.2× 148 0.5× 90 0.4× 157 1.0× 110 1.3× 39 963

Countries citing papers authored by Yepeng Luan

Since Specialization
Citations

This map shows the geographic impact of Yepeng Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yepeng Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yepeng Luan more than expected).

Fields of papers citing papers by Yepeng Luan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yepeng Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yepeng Luan. The network helps show where Yepeng Luan may publish in the future.

Co-authorship network of co-authors of Yepeng Luan

This figure shows the co-authorship network connecting the top 25 collaborators of Yepeng Luan. A scholar is included among the top collaborators of Yepeng Luan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yepeng Luan. Yepeng Luan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Jinhong, et al.. (2023). Development of VER-50589 analogs as novel Hsp90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 91. 129375–129375. 1 indexed citations
2.
Nie, Jing, et al.. (2023). The Development of HDAC and Tubulin Dual-Targeting Inhibitors forCancer Therapy. Mini-Reviews in Medicinal Chemistry. 24(5). 480–490. 3 indexed citations
3.
4.
Li, Jing, et al.. (2022). Design, synthesis and antitumor activity study of PARP-1/HDAC dual targeting inhibitors. Bioorganic & Medicinal Chemistry Letters. 71. 128821–128821. 17 indexed citations
5.
Li, Yongliang, et al.. (2022). Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor. Bioorganic & Medicinal Chemistry Letters. 72. 128881–128881. 12 indexed citations
6.
Lv, Mengqi, Han Wu, Siyi Wu, et al.. (2021). The design and synthesis of transient receptor potential vanilloid 3 inhibitors with novel skeleton. Bioorganic Chemistry. 114. 105115–105115. 7 indexed citations
7.
Zhao, Wenwen, et al.. (2021). Design, synthesis and antitumor activity evaluation of novel HDAC inhibitors with tetrahydrobenzothiazole as the skeleton. Bioorganic Chemistry. 108. 104652–104652. 11 indexed citations
8.
Zhang, Chen, et al.. (2020). Organocatalytic Enantioselective Regiodivergent C−H Bond Functionalization of 1‐Naphthols with 1‐Azadienes. Advanced Synthesis & Catalysis. 362(6). 1286–1291. 34 indexed citations
9.
Wang, Baolei, Xuehong Chen, Jianjun Gao, et al.. (2019). Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(18). 2638–2645. 33 indexed citations
10.
11.
Zhang, Xiaoli, Jiyong Wu, & Yepeng Luan. (2016). Tip60: Main Functions and Its Inhibitors. Mini-Reviews in Medicinal Chemistry. 17(8). 675–682. 16 indexed citations
12.
Li, Wenjun, Xiao Zhou, Yepeng Luan, & Jian Wang. (2015). Direct access to 1,4-disubstituted 1,2,3-triazoles through organocatalytic 1,3-dipolar cycloaddition reaction of α,β-unsaturated esters with azides. RSC Advances. 5(108). 88816–88820. 18 indexed citations
13.
Luan, Yepeng, Levi L. Blazer, Hao Hu, et al.. (2015). Design of a fluorescent ligand targeting the S-adenosylmethionine binding site of the histone methyltransferase MLL1. Organic & Biomolecular Chemistry. 14(2). 631–638. 15 indexed citations
14.
Cai, Shengxin, et al.. (2014). Secondary metabolites of a deep sea derived fungus Aspergillus versicolor CXCTD-06-6a and their bioactivity. Journal of Ocean University of China. 13(4). 691–695. 13 indexed citations
15.
Luan, Yepeng, et al.. (2012). Lysosomotropic Properties of Weakly Basic Anticancer Agents Promote Cancer Cell Selectivity In Vitro. PLoS ONE. 7(11). e49366–e49366. 30 indexed citations
16.
Luan, Yepeng, et al.. (2012). The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family. Current Protein and Peptide Science. 13(5). 490–500. 9 indexed citations
17.
Luan, Yepeng, Fanbo Jing, Jian Zhang, et al.. (2012). Design, Synthesis, and Activity Evaluation of a New 5-fluorouracil Prodrug Containing an Asn-Gly-Arg(NO2)COOCH3 Tripeptide. Protein and Peptide Letters. 19(10). 1122–1131. 7 indexed citations
18.
Luan, Yepeng, Chunhua Ma, Xuejian Wang, et al.. (2010). LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition. Medicinal Chemistry. 7(1). 32–36. 7 indexed citations
19.
Wang, Qiang, Fuming Xu, Jian Zhang, et al.. (2010). Design, Synthesis and Preliminary Activity Evaluation of Novel L-Lysine Derivatives as Aminopeptidase N/CD13 Inhibitors. Protein and Peptide Letters. 17(7). 847–853. 3 indexed citations
20.
Luan, Yepeng & Wenfang Xu. (2007). The Structure and Main Functions of Aminopeptidase N. Current Medicinal Chemistry. 14(6). 639–647. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.M. Soisson Breakdown of academic impact, for papers by Kouhei Matsui Breakdown of academic impact, for papers by Paola Lo Surdo Breakdown of academic impact, for papers by Patrick Vlieghe Breakdown of academic impact, for papers by Pengfei Fang Breakdown of academic impact, for papers by Yaxue Zhao Breakdown of academic impact, for papers by Salvatore Di Maro Breakdown of academic impact, for papers by Charles A. Omer Breakdown of academic impact, for papers by Tomowo Kobayashi Breakdown of academic impact, for papers by Juan Manuel Domı́nguez
Rankless by CCL
2026